Linda N. Liu

Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer

Kristin J. Lastwika, Willie Wilson, Qing Kay Li et al. · Cancer Research · 2015 · 764 citations

Immunology, Immune Regulation, Immunoediting +20

Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy

Jun Wang, Jingwei Sun, Linda N. Liu et al. · Nature Medicine · 2019 · 678 citations · Full text

Cancer Immunosurveillance, Normalization Cancer Immunotherapy, Medicine +10

Highly Efficient, Large Volume Flow Electroporation

Linhong Li, Rama Shivakumar, Stephanie Feller et al. · Technology in Cancer Research & Treatment · 2002 · 60 citations

Electrical Engineering, Electrohydrodynamics, Engineering +14

B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms

Joseph R. Podojil, Linda N. Liu, Shannon Marshall et al. · Journal of Autoimmunity · 2013 · 54 citations · Full text

Autoimmune Disease, Il-10/treg-dependent Mechanisms, Adaptive Immune System +11

Comparison of Drug and Cell-Based Delivery: Engineered Adult Mesenchymal Stem Cells Expressing Soluble Tumor Necrosis Factor Receptor II Prevent Arthritis in Mouse and Rat Animal Models

Linda N. Liu, Gang Wang, Kyle Hendricks et al. · Stem Cells Translational Medicine · 2013 · 54 citations · Full text

Tissue Engineering, Cell Therapy, Adult Stem Cell +31